<?xml version="1.0" encoding="UTF-8"?><mods xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" ID="id-2026-13581">
    <name type="corporate">
        <namePart>United States Government Publishing Office</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">publisher</roleTerm>
            <roleTerm authority="marcrelator" type="code">pbl</roleTerm>
        </role>
        <role>
            <roleTerm authority="marcrelator" type="text">distributor</roleTerm>
            <roleTerm authority="marcrelator" type="code">dst</roleTerm>
        </role>
    </name>
    <name type="corporate">
        <namePart>United States</namePart>
        <namePart>National Archives and Records Administration</namePart>
        <namePart>Office of the Federal Register</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">author</roleTerm>
            <roleTerm authority="marcrelator" type="code">aut</roleTerm>
        </role>
        <description>Government Organization</description>
    </name>
    <typeOfResource>text</typeOfResource>
    <genre authority="marcgt">government publication</genre>
    <language>
        <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
    </language>
    <extension>
        <collectionCode>FR</collectionCode>
        <category>Regulatory Information</category>
        <waisDatabaseName>2026_register</waisDatabaseName>
        <branch>executive</branch>
        <dateIngested>2026-07-03</dateIngested>
    </extension>
    <genre authority="marcgt">article</genre>
    <titleInfo>
        <title>Schedules of Controlled Substances: Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I</title>
        <partName>Proposed Rules</partName>
    </titleInfo>
    <relatedItem type="otherFormat" xlink:href="https://www.govinfo.gov/content/pkg/FR-2026-07-06/html/2026-13581.htm">
        <identifier type="FDsys Unique ID">D09002ee1e449a80e</identifier>
    </relatedItem>
    <relatedItem type="otherFormat" xlink:href="https://www.govinfo.gov/content/pkg/FR-2026-07-06/pdf/2026-13581.pdf">
        <identifier type="FDsys Unique ID">D09002ee1e449a8f9</identifier>
    </relatedItem>
    <name type="corporate">
        <namePart>United States</namePart>
        <namePart>Department of Justice</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">originator</roleTerm>
            <roleTerm authority="marcrelator" type="code">org</roleTerm>
        </role>
        <description>United States Government Agency or Subagency</description>
    </name>
    <name type="corporate">
        <namePart>United States</namePart>
        <namePart>Drug Enforcement Administration</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">originator</roleTerm>
            <roleTerm authority="marcrelator" type="code">org</roleTerm>
        </role>
        <description>United States Government Agency or Subagency</description>
    </name>
    <abstract>The Administrator of the Drug Enforcement Administration is issuing this notice of intent to publish a temporary order to schedule three 7-hydroxymitragynine-related substances (mitragynine pseudoindoxyl, MGM-15, and MGM-16), including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible, in schedule I of the Controlled Substances Act. When it is issued, the temporary scheduling order will impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle these three 7-hydroxymitragynine-related substances.</abstract>
    <identifier type="FR citation">91 FR 40909</identifier>
    <identifier type="uri">https://www.govinfo.gov/app/details/FR-2026-07-06/2026-13581</identifier>
    <identifier type="FR Doc No.">2026-13581</identifier>
    <identifier type="former granule identifier">fr06jy26-22</identifier>
    <identifier type="billing code">P</identifier>
    <identifier type="department code">Docket No. DEA-1644</identifier>
    <location>
        <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/FR-2026-07-06/2026-13581</url>
        <url access="raw object" displayLabel="HTML rendition">https://www.govinfo.gov/content/pkg/FR-2026-07-06/html/2026-13581.htm</url>
        <url access="raw object" displayLabel="PDF rendition">https://www.govinfo.gov/content/pkg/FR-2026-07-06/pdf/2026-13581.pdf</url>
    </location>
    <subject>
        <topic>Administrative Practice and Procedure</topic>
        <topic>Drug Traffic Control</topic>
        <topic>Reporting and Recordkeeping Requirements</topic>
    </subject>
    <physicalDescription>
        <extent>8 p.</extent>
    </physicalDescription>
    <part type="Proposed Rules">
        <extent unit="pages">
            <start>40909</start>
            <end>40916</end>
        </extent>
    </part>
    <identifier type="preferred citation">91 FR 40909</identifier>
    <relatedItem type="isReferencedBy">
        <titleInfo>
            <title>Code of Federal Regulations</title>
            <partNumber>Title 21 Part 1308</partNumber>
        </titleInfo>
        <identifier type="CFR citation">21 CFR Part  1308</identifier>
    </relatedItem>
    <extension>
        <searchTitle>Schedules of Controlled Substances: Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I; Federal Register Vol. 91, Issue </searchTitle>
        <granuleClass>PRORULE</granuleClass>
        <accessId>2026-13581</accessId>
        <agency order="1">DEPARTMENT OF JUSTICE</agency>
        <agency order="2">Drug Enforcement Administration</agency>
        <departmentDoc>Docket No. DEA-1644</departmentDoc>
        <billingCode>P</billingCode>
        <frDocNumber>2026-13581</frDocNumber>
        <action>Proposed amendment; notice of intent.</action>
        <summary>The Administrator of the Drug Enforcement Administration is issuing this notice of intent to publish a temporary order to schedule three 7-hydroxymitragynine-related substances (mitragynine pseudoindoxyl, MGM-15, and MGM-16), including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible, in schedule I of the Controlled Substances Act. When it is issued, the temporary scheduling order will impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle these three 7-hydroxymitragynine-related substances.</summary>
        <dates>July 6, 2026.</dates>
        <contact>Terrence L. Boos, Drug and Chemical Evaluation Section, Diversion Control Division, Drug Enforcement</contact>
        <cfr title="21">
                                    
            <part number="1308"/>
                                    
            <subject>Administrative Practice and Procedure</subject>
                                    
            <subject>Drug Traffic Control</subject>
                                    
            <subject>Reporting and Recordkeeping Requirements</subject>
                                
        </cfr>
        <tocSubject1>Schedules of Controlled Substances</tocSubject1>
        <tocDoc>Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I, </tocDoc>
        <urlRef>https://cbdamericanshaman.com/pseudoindoxyl-chewable-tablets-red-vein-advanced-alkaloids</urlRef>
        <urlRef>https://getwelldepot.com/mgm/</urlRef>
        <urlRef>https://greatcbdshop.com/product-category/brands/kama-kratom/</urlRef>
        <urlRef>https://pureleafkratom.com/kama-kratom/</urlRef>
        <urlRef>https://pureleafkratom.com/products/dozo-perks-100mg-pseudoindoxyl-grape-chewable-tablets-4ct.html</urlRef>
        <urlRef>https://www.7ohfactory.com/products/30mg-mgm-15-tablets-berries</urlRef>
        <urlRef>https://www.cfsre.org/nps-discovery/monographs/dihydro-7-hydroxy-mitragynine</urlRef>
        <urlRef>https://www.cfsre.org/nps-discovery/monographs/mitragynine-pseudoindoxyl</urlRef>
        <urlRef>https://www.reddit.com/r/KratomKorner/comments/1kpz2u3/can_anyone_help_with_the_mgm_16_rumors/?rdt=48097</urlRef>
        <urlRef>www.regulations.gov</urlRef>
    </extension>
    <relatedItem type="host" ID="P0b002ee1e44609ce" xlink:href="https://www.govinfo.gov/metadata/pkg/FR-2026-07-06/mods.xml">
        <titleInfo>
            <title>Federal Register</title>
            <partNumber>Vol. 91, no. 127</partNumber>
        </titleInfo>
        <originInfo>
            <publisher>Office of the Federal Register, National Archives and Records Administration</publisher>
            <dateIssued encoding="w3cdtf">2026-07-06</dateIssued>
            <issuance>continuing</issuance>
            <frequency>daily</frequency>
        </originInfo>
        <physicalDescription>
            <note type="source content type">deposited</note>
            <digitalOrigin>born digital</digitalOrigin>
            <extent>669 p.</extent>
        </physicalDescription>
        <tableOfContents xlink:href="https://www.govinfo.gov/app/frtoc/2026-07-06">    
		  Table of Contents: 
		</tableOfContents>
        <classification authority="sudocs">AE 2.7:</classification>
        <classification authority="sudocs">GS 4.107:</classification>
        <classification authority="sudocs">AE 2.106:</classification>
        <classification authority="lcc">KF70.A2</classification>
        <identifier type="uri">https://www.govinfo.gov/app/details/FR-2026-07-06</identifier>
        <identifier type="local">P0b002ee1e44609ce</identifier>
        <identifier type="issn">0097-6326</identifier>
        <identifier type="issn">0042-1219</identifier>
        <identifier type="issn">0364-1406</identifier>
        <identifier type="stock number">769-004-00000-9</identifier>
        <identifier type="ILS system id">000582072</identifier>
        <identifier type="former identifier">f:fr06jy26</identifier>
        <location>
            <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/FR-2026-07-06</url>
            <url displayLabel="PDF rendition" access="raw object">https://www.govinfo.gov/content/pkg/FR-2026-07-06/pdf/FR-2026-07-06.pdf</url>
            <url displayLabel="XML rendition" access="raw object">https://www.govinfo.gov/content/pkg/FR-2026-07-06/xml/FR-2026-07-06.xml</url>
        </location>
        <accessCondition type="GPO scope determination">fdlp</accessCondition>
        <part type="issue">
            <extent unit="pages">
                <start>40859</start>
                <end>41519</end>
            </extent>
        </part>
        <recordInfo>
            <recordContentSource authority="marcorg">DGPO</recordContentSource>
            <recordCreationDate encoding="w3cdtf">2026-07-03</recordCreationDate>
            <recordChangeDate encoding="w3cdtf">2026-07-03</recordChangeDate>
            <recordIdentifier source="DGPO">FR-2026-07-06</recordIdentifier>
            <recordOrigin>machine generated</recordOrigin>
            <languageOfCataloging>
                <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
            </languageOfCataloging>
        </recordInfo>
        <extension>
            <docClass>FR</docClass>
            <accessId>FR-2026-07-06</accessId>
            <volume>91</volume>
            <issue>127</issue>
        </extension>
    </relatedItem>
</mods>
